Lv3
320 积分 2023-10-27 加入
Abstract 347: Novel EGFR x cMET bispecific ADC GQ1033 and DLL3-ADC GQ1030 demonstrated promising therapeutic efficacy in preclinical studies
12小时前
求助中
A phase I open-label study to evaluate safety, tolerability and pharmacokinetic (PK) profile of VB4–845, an anti-EpCAM immunotoxin, in subjects with SCCHN
18天前
已关闭
Screening Peptides that Activate MRGPRX2 using Engineered HEK Cells
21天前
已完结
Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders
24天前
已完结
Design of a Fibroblast Activation Protein–Targeted Radiopharmaceutical Therapy with High Tumor–to–Healthy-Tissue Ratios
26天前
已完结
152 (PB140): MC339, a novel radiopharmaceutical, targets DLL3-expressing cancers of different tissue origins
1个月前
已完结
MC1R Peptide Agonist Self-Assembles into a Hydrogel That Promotes Skin Pigmentation for Treating Vitiligo
1个月前
已完结
Preclinical evaluation of 203/212Pb-based theranostics-dosimetry and renal toxicity
2个月前
已关闭
Discovery of MT-7117 (Dersimelagon Phosphoric Acid): A Novel, Potent, Selective, and Nonpeptidic Orally Available Melanocortin 1 Receptor Agonist
2个月前
已完结
皖公网安备34019202002308
